<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>PANDAS: Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">PANDAS: Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">PANDAS: Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael E Pichichero, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Douglas R Nordli, Jr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marisa Klein-Gitelman, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 25, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>An overview of pediatric autoimmune neuropsychiatric disorder associated with group A streptococci (PANDAS) will be presented below. The diagnosis, complications, and treatment of group A streptococcal (GAS) infection, obsessive-compulsive disorder, and tic disorders in children are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5971.html" rel="external">"Group A streptococcal tonsillopharyngitis in children and adolescents: Clinical features and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/8046.html" rel="external">"Complications of streptococcal tonsillopharyngitis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/8049.html" rel="external">"Treatment and prevention of streptococcal pharyngitis in adults and children"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/86436.html" rel="external">"Obsessive-compulsive disorder in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6221.html" rel="external">"Tourette syndrome: Pathogenesis, clinical features, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H1795949748"><span class="h1">TERMINOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>PANDAS</strong> – Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci (PANDAS) is a term used to describe a subset of children whose symptoms of obsessive-compulsive disorder, tic disorders, or other neuropsychiatric symptoms (eg, anxiety) are exacerbated by GAS infection [<a href="#rid1">1,2</a>]. The hypothesized association between PANDAS and GAS is controversial, as is the limitation of the diagnosis exclusively to the pediatric age group. (See <a class="local">'Areas of controversy'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>PANS/CANS </strong>– Pediatric acute-onset neuropsychiatric syndrome (PANS), sometimes referred to as childhood acute neuropsychiatric symptoms (CANS), is a diagnostic entity introduced to broaden the scope of these disorders and allow for inciting events other than GAS [<a href="#rid3">3</a>].</p><p></p><p>This topic focuses on PANDAS. Detailed discussion of PANS/CANS is beyond the scope of this review, but available in review articles published in 2021 [<a href="#rid4">4,5</a>].</p><p class="headingAnchor" id="H2"><span class="h1">BACKGROUND</span></p><p class="headingAnchor" id="H2184550760"><span class="h2">Historical perspective</span><span class="headingEndMark"> — </span>Most of the knowledge about PANDAS has been obtained by studying patients with a known tic disorder or long-standing obsessive-compulsive disorder (OCD) in research facilities and referral centers [<a href="#rid1">1,6-8</a>]. Investigators at these centers noted an association between Sydenham chorea and OCD [<a href="#rid9">9-11</a>]. Sydenham chorea is a movement disorder characterized by chorea, emotional lability, and hypotonia. It is one of the major clinical manifestations of acute rheumatic fever. The investigators also identified a subset of children with OCD or tic disorders following GAS infection who did not meet criteria for Sydenham chorea [<a href="#rid8">8,12,13</a>]. This subset is described by the acronym PANDAS [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/d/html/6228.html" rel="external">"Sydenham chorea"</a> and  <a class="medical medical_review" href="/d/html/3177.html" rel="external">"Acute rheumatic fever: Clinical manifestations and diagnosis"</a>.)</p><p>The diagnostic criteria for PANDAS include [<a href="#rid1">1,14</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>OCD and/or tic disorder (Tourette syndrome, chronic motor or vocal tic disorder)</p><p class="bulletIndent1"><span class="glyph">●</span>Pediatric onset (between three years and onset of puberty)</p><p class="bulletIndent1"><span class="glyph">●</span>Abrupt onset and episodic course of symptoms</p><p class="bulletIndent1"><span class="glyph">●</span>Temporal relation between GAS infection and onset and/or exacerbation</p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic abnormalities, such as motoric hyperactivity, choreiform movements, or tics during exacerbations</p><p></p><p>In the original description of 50 patients with PANDAS in 1998, approximately 40 percent of all presentations and exacerbations were related to preceding or concurrent GAS infections and each patient had at least one episode in which the relationship to GAS was established [<a href="#rid1">1</a>]. In 2012, PANDAS investigators proposed modifying the PANDAS criteria to describe pediatric acute-onset neuropsychiatric syndrome (PANS), also called also called childhood acute neuropsychiatric symptoms [<a href="#rid3">3</a>].</p><p>The proposed diagnostic criteria for PANS include all three of the following [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Abrupt, dramatic overnight onset of OCD or severely restricted food intake</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Concurrent abrupt onset of additional severe neuropsychiatric symptoms from at least two of the following seven categories:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anxiety</p><p class="bulletIndent2"><span class="glyph">•</span>Emotional lability and/or depression</p><p class="bulletIndent2"><span class="glyph">•</span>Irritability, aggression, and/or severe oppositional behaviors</p><p class="bulletIndent2"><span class="glyph">•</span>Developmental regression</p><p class="bulletIndent2"><span class="glyph">•</span>Deterioration in school performance</p><p class="bulletIndent2"><span class="glyph">•</span>Sensory or motor abnormalities, including heightened sensitivity to sensory stimuli, hallucinations, dysgraphia, complex motor and/or vocal tics</p><p class="bulletIndent2"><span class="glyph">•</span>Somatic signs and symptoms, including sleep disturbances, enuresis, or urinary frequency</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Symptoms are not better explained by a known neurologic or medical disorder</p><p></p><p>Whether PANDAS is a distinct form of more typical cases of OCD or tic disorder and the proposed pathogenesis are controversial [<a href="#rid15">15-20</a>]. (See <a class="local">'Areas of controversy'</a> below.)</p><p>However, the author of this topic agrees with the commentary by Wald: "For those of us familiar with the sequelae of streptococcal disease and the concerns of community physicians faced with the care of children with these neuropsychiatric symptoms, the controversy has proven to be a disservice to both pediatricians and families. It has fostered a dismissive attitude toward important clinical observations" [<a href="#rid18">18,21</a>]. Continued study is essential to better address the concerns of families of children with neuropsychiatric symptoms and their health care providers. Whether PANS is a distinct entity is also controversial. The reported pathogens include <em>Mycoplasma pneumoniae</em>, enteroviruses, <em>Chlamydia pneumoniae</em>, <em>Borrelia burgdorferi, Toxoplasma gondii</em>, and human immunodeficiency virus (HIV) [<a href="#rid4">4,22</a>]. However, evidence regarding the association among infectious pathogens other than GAS and OCD, tic, and other neuropsychiatric disorders are largely based on small numbers of cases or case reports.</p><p class="headingAnchor" id="H3"><span class="h2">Areas of agreement</span><span class="headingEndMark"> — </span>There is general agreement on the following points:</p><p class="bulletIndent1"><span class="glyph">●</span>GAS is one of several factors that can exacerbate OCD or tic disorder in a subset of patients [<a href="#rid1">1,13,23-27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with signs and symptoms compatible with GAS infections should be evaluated for GAS infection [<a href="#rid14">14,16</a>]. (See  <a class="medical medical_review" href="/d/html/5971.html" rel="external">"Group A streptococcal tonsillopharyngitis in children and adolescents: Clinical features and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Children with GAS infection and OCD/tic disorder require standard treatments for these problems (regardless of whether GAS and OCD/tic disorder are causally associated) [<a href="#rid14">14,16</a>]. (See <a class="local">'Management'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sydenham chorea is a manifestation of GAS infection and up to 70 percent of patients with Sydenham chorea have psychiatric symptoms; in patients with recurrent chorea, 100 percent have psychiatric symptoms [<a href="#rid6">6,28</a>]. (See  <a class="medical medical_review" href="/d/html/6228.html" rel="external">"Sydenham chorea", section on 'Neuropsychiatric symptoms'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There can be a one- to eight-month latency period between GAS infection and onset of nonsuppurative poststreptococcal sequelae such as Sydenham chorea and acute rheumatic fever. Therefore, when sequelae become clinically apparent, detection of GAS by culture or serology may not occur.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pharyngeal GAS infections that precede development of nonsuppurative sequelae may be subclinical or mild [<a href="#rid29">29,30</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Not all strains of GAS cause nonsuppurative sequelae, and infection with a rheumatogenic strain is followed by nonsuppurative sequelae in only 0.1 to 5 percent of infected, untreated patients, suggesting a genetic component to susceptibility [<a href="#rid31">31</a>]. (See  <a class="medical medical_review" href="/d/html/3151.html" rel="external">"Acute rheumatic fever: Epidemiology and pathogenesis", section on 'Pathogenesis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Interpretation of antistreptococcal serology is complicated by multiple factors, including an inconsistent response to acute GAS infections and GAS asymptomatic carriage [<a href="#rid32">32</a>].</p><p></p><p class="headingAnchor" id="H4"><span class="h2">Areas of controversy</span><span class="headingEndMark"> — </span>Controversies surrounding PANDAS include:</p><p class="bulletIndent1"><span class="glyph">●</span>Is PANDAS sufficiently different from OCD/tic disorder and other neuropsychiatric disorders to be considered a separate entity [<a href="#rid23">23,26,33,34</a>]? (See <a class="local">'Clinical features'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Is the association between GAS and PANDAS authentic [<a href="#rid17">17,20,23,26,34-39</a>]? (See <a class="local">'Epidemiology and association with GAS'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Is PANDAS an autoimmune disorder [<a href="#rid33">33,34,36,40</a>]? (See <a class="local">'Pathogenesis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Should evidence of GAS infection be sought in patients with OCD/tic disorders or other neuropsychiatric symptoms [<a href="#rid15">15,16,41</a>]? (See <a class="local">'Diagnostic process'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Is administration of immunomodulatory therapy (eg, glucocorticoids, plasma exchange, intravenous <a class="drug drug_pediatric" data-topicid="83878" href="/d/drug information/83878.html" rel="external">immune globulin</a>) warranted for children who meet PANDAS or PANS criteria [<a href="#rid14">14,16,42</a>]?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Is administration of prophylactic antibiotics warranted for children who meet PANDAS criteria [<a href="#rid14">14,16</a>]?</p><p></p><p class="headingAnchor" id="H5"><span class="h1">PATHOGENESIS</span></p><p class="headingAnchor" id="H4136731270"><span class="h2">Pathogenetic models</span></p><p class="bulletIndent1"><span class="glyph">●</span>The major model for PANDAS pathogenesis is based upon the clinical similarities between Sydenham chorea and PANDAS [<a href="#rid1">1</a>]. The pathogenesis of Sydenham chorea and acute rheumatic fever involve a preceding GAS pharyngitis infection and an abnormal immune response (in which antibodies directed against GAS antigens cross-react with host antigens in brain and heart valves) are widely accepted as important components. (See  <a class="medical medical_review" href="/d/html/3151.html" rel="external">"Acute rheumatic fever: Epidemiology and pathogenesis", section on 'Molecular mimicry'</a>.)</p><p></p><p class="bulletIndent1">The autoimmune complications of GAS infections are caused by an atypical immune response to antigens of GAS bacteria that cross-react with self-tissues. Children between the ages of 5 and 12 years are more susceptible to autoimmune complications because they have more frequent exposure and typically respond to GAS (and other infections) with higher quantities of antibodies than older adolescents and adults. The more controlled response in older adolescents and adults may be related to immune mechanisms that dampen proinflammatory processes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Another proposed model is based on studies in animals and humans, including children with pediatric acute-onset neuropsychiatric syndrome/PANDAS, that suggest that alterations of gut microbiota are associated with neuroinflammation [<a href="#rid43">43-45</a>]. In a case-control study, 30 children with PANDAS had higher circulating levels of markers of oxidative stress (eg, soluble NOX2, isoprostanes) than 30 age- and sex-matched controls [<a href="#rid46">46</a>].</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Epidemiology and association with GAS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – The incidence and prevalence of PANDAS are not known, although it is rare. In a prospective study, only 10 cases were identified among 30,000 throat cultures positive for GAS [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1">In the original description of PANDAS in 50 patients, the mean age of onset was 6.3 years for children with tics and 7.4 years for children with obsessive-compulsive disorder (OCD) [<a href="#rid1">1</a>]. The overall ratio of males to females with PANDAS was 2.6 to 1, and among children under eight years of age the ratio was 4.7 to 1. PANDAS was more common among children with a family history of rheumatic fever.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiologic studies of PANDAS association with GAS</strong> – An association between neuropsychiatric symptoms or PANDAS and GAS infection has been assessed in multiple studies with varying conclusions.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>GAS and neuropsychiatric symptoms – In a case-control study from a large health maintenance organization with a population of approximately 75,000 children, 144 patients with OCD, Tourette syndrome, or a tic disorder were matched with one to five controls [<a href="#rid13">13</a>]. Cases were more likely than controls to have had a GAS infection in the three months before the onset of neurologic disease (odds ratio [OR] 2.2, 95% CI 1.1-4.7) and to have had multiple GAS infections during the 12 months before the onset of neurologic disease (OR 3.1, 95% CI 1.8-9.0).</p><p></p><p class="bulletIndent2">Similarly, prospective studies suggest that GAS is associated with the onset or exacerbation of OCD or tic disorder or other neuropsychiatric symptoms in a subset of patients [<a href="#rid23">23,24</a>]. In a population-based cohort study including more than one million children in Denmark, children with a streptococcal throat infection had increased risks of OCD and tic disorders [<a href="#rid27">27</a>]. Other investigators analyzing data from the same cohort affirmed an association between infections and neuropsychiatric disorders but did not specifically evaluate GAS infections [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent2">In another longitudinal study, in which 693 children were evaluated monthly (October through May) with throat cultures and for behaviors (eg, fidgeting, balance/swaying, non-tic facial movements), tics, and choreiform movements, there was an association between GAS infection in the previous three months and behaviors and between repeated GAS infection and behaviors and choreiform movements [<a href="#rid48">48</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>GAS and PANDAS – In contrast, several epidemiologic studies have failed to identify an association of GAS infections with PANDAS [<a href="#rid38">38</a>]. In a prospective study, although children diagnosed with PANDAS had a higher rate of exacerbations than control children with OCD or Tourette syndrome without a history of PANDAS, most of the exacerbations in children with PANDAS had no observable association with GAS infection [<a href="#rid23">23</a>]. In another prospective study, the number of clinical exacerbations and newly diagnosed GAS infections were similar in children diagnosed with PANDAS and children with OCD or Tourette syndrome without a history of PANDAS [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1">Taken together, these studies do not provide definitive answers. Although some studies detected an association between GAS and OCD/tic disorder exacerbations, the high background rates of GAS infection, GAS carriage, and OCD/tic disorders in prepubertal children make it difficult to establish causality [<a href="#rid14">14,16,17,20</a>]. The studies that did not detect a clear association between GAS and OCD/tic disorder exacerbations may have been limited by small sample size, antibiotic treatment of GAS preventing nonsuppurative sequelae, or, possibly, differences in genetic susceptibility and PANDAS-specific GAS strains.</p><p></p><p class="headingAnchor" id="H7"><span class="h2">Autoimmunity</span><span class="headingEndMark"> — </span>Similar to Sydenham chorea and acute rheumatic fever, molecular mimicry (ie, production of autoantibodies following GAS infections that target cells of the basal ganglia) is the proposed pathogenesis of PANDAS.</p><p>Multiple studies have demonstrated increased antineuronal antibodies in patients with PANDAS compared with patients with OCD/tic disorders without evidence of GAS infection and patients with GAS infection without OCD/tic disorder [<a href="#rid22">22,34,49-66</a>]. However, other studies have been unable to distinguish patients with PANDAS or Tourette syndrome from control patients on the basis of autoantibody profiles [<a href="#rid67">67-70</a>]. The inconsistent findings may be related to methodologic differences [<a href="#rid71">71,72</a>]. As an example, the control sera used in different studies may have different antineuronal antibody concentrations [<a href="#rid64">64</a>].</p><p>Support for a role of autoimmunity is provided by reports of response to treatment with immune-modifying therapies, such as glucocorticoids, intravenous <a class="drug drug_pediatric" data-topicid="83878" href="/d/drug information/83878.html" rel="external">immune globulin</a>, and plasma exchange [<a href="#rid8">8,49,50,73</a>]. The response to plasma exchange appears to be specific to children with OCD/tic disorders and preceding GAS infection; in an open trial, plasma provided no benefit for children with OCD whose symptom exacerbation did not follow GAS infection [<a href="#rid74">74</a>].</p><p>An autoimmune mechanism for PANDAS also is supported by animal studies. Rodents hyperimmunized with GAS have been reported to demonstrate behaviors consistent with PANDAS [<a href="#rid62">62</a>]. When transferred to naïve animals, serum from hyperimmunized rodents displaying PANDAS behaviors produced PANDAS behaviors [<a href="#rid63">63,75</a>]. Although human sera from PANDAS patients failed to induce PANDAS behaviors in a rodent model [<a href="#rid76">76</a>], human sera from PANDAS patients has been shown to bind to cholinergic interneurons in rodents [<a href="#rid77">77</a>].</p><p class="headingAnchor" id="H9"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H593033002"><span class="h2">Working diagnostic criteria</span><span class="headingEndMark"> — </span>PANDAS is characterized by five working criteria [<a href="#rid1">1,8,14</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Obsessive-compulsive disorder (OCD) and/or tic disorder (Tourette syndrome, chronic motor or vocal tic disorder that meets the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition diagnostic criteria). (See  <a class="medical medical_review" href="/d/html/86436.html" rel="external">"Obsessive-compulsive disorder in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6221.html" rel="external">"Tourette syndrome: Pathogenesis, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6232.html" rel="external">"Hyperkinetic movement disorders in children", section on 'Tic disorders'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pediatric onset (between three years and onset of puberty). (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abrupt onset and episodic course of symptoms. (See <a class="local">'Clinical course'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Temporal relation between GAS infection and onset and/or exacerbation. The time frame for the temporal relation was not specified in the original description [<a href="#rid1">1</a>]. Antibody levels to streptolysin O and DNase B remain elevated for several months after an acute infection, complicating the applicability and interpretation of elevated titers [<a href="#rid78">78</a>]. (See <a class="local">'Diagnostic process'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic abnormalities, such as motoric hyperactivity (eg, fidgeting, difficulty remaining seated), choreiform movements (elicited through stressed postures [eg, standing upright with the feet together and the eyes closed, holding the arms outstretched with the hands extended] but not present at rest), or tics during exacerbations. Frank chorea (rapid, irregular, and nonstereotypic jerks that are continuous while the patient is awake but improve with sleep) suggests Sydenham chorea. (See  <a class="medical medical_review" href="/d/html/6228.html" rel="external">"Sydenham chorea"</a>.)</p><p></p><p>Observational studies suggest that clinical and laboratory features can distinguish PANDAS from OCD or tic disorder without PANDAS:</p><p class="bulletIndent1"><span class="glyph">●</span>In a prospective study, 12 children with PANDAS were identified in a primary care practice over a three-year period [<a href="#rid24">24</a>]. All had positive throat cultures at the time of onset of neuropsychiatric symptoms and improvement of neuropsychiatric symptoms with antibiotic therapy. Symptoms resolved completely in four patients within 5 to 21 days after onset, and none of these patients had a recurrence. Recurrent symptoms developed in the remaining children, and each recurrence was associated with a new episode of culture-proven GAS tonsillopharyngitis and amelioration of symptoms with antibiotic therapy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study of 109 prepubertal children with tics, OCD, or both, clinical features that were more frequent among the 48 children who met criteria for PANDAS included dramatic onset of symptoms, remissions in neuropsychiatric symptoms, a clinical course marked by definite remissions, and remission of neuropsychiatric symptoms during antibiotic therapy [<a href="#rid2">2</a>].</p><p></p><p>However, some experts have questioned whether these studies are useful, challenging whether they distinguished patients with PANDAS from patients with more typical cases of OCD, tic disorder, or other neuropsychiatric disorders [<a href="#rid15">15,16,33</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Clinical course</span><span class="headingEndMark"> — </span>The most striking feature of PANDAS is the abrupt onset [<a href="#rid1">1,24</a>]. However, abrupt onset of OCD/tic disorder symptoms also has been noted in patients without PANDAS [<a href="#rid17">17,79</a>]. Subsequently, the clinical course of PANDAS may be characterized by a "sawtooth" pattern with periods of symptom quiescence, followed by exacerbations with abrupt onset and gradual resolution (over weeks to months) [<a href="#rid1">1,8,14,24</a>]. Neuropsychiatric exacerbations in children with PANDAS may begin at the time of GAS infection or within weeks after GAS infection; however, symptom onset may be delayed by one to eight months, similar to Sydenham chorea and acute rheumatic fever, when culture evidence of GAS will be absent [<a href="#rid1">1,14,24</a>].</p><p>Children with PANDAS and tics occasionally have simultaneous onset of frequent, severe, and varied motor and vocal tics, prompting caregivers to seek emergency treatment [<a href="#rid14">14</a>]. This is in contrast to the typical onset of isolated, intermittent, simple motor or vocal tic that has a much more gradual onset and is milder [<a href="#rid14">14,80</a>].</p><p>Children with PANDAS have been described as having an "explosion" of OCD symptoms, reaching clinically significant impairment in 24 to 48 hours [<a href="#rid1">1</a>]. This is in contrast to the typical undulating waxing and waning pattern of OCD symptoms in patients without PANDAS [<a href="#rid81">81,82</a>]. (See  <a class="medical medical_review" href="/d/html/86436.html" rel="external">"Obsessive-compulsive disorder in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis", section on 'Course'</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">DIAGNOSTIC PROCESS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>When to consider the diagnosis</strong> – The author of this topic suggests that children who present with abrupt onset of obsessive-compulsive disorder (OCD)/tic disorder, separation anxiety, or urinary frequency (which can be a form of anxiety) be evaluated for PANDAS by testing for GAS infection [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation for GAS infection</strong> – Evidence of GAS is provided by one of the following [<a href="#rid1">1,14,83</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A positive throat culture, rapid antigen detection test (RADT), or molecular assay for GAS pharyngitis or positive skin culture from infected skin. (See  <a class="medical medical_review" href="/d/html/5971.html" rel="external">"Group A streptococcal tonsillopharyngitis in children and adolescents: Clinical features and diagnosis", section on 'Microbiologic tests'</a>.)</p><p></p><p class="bulletIndent2">RADT results may be inaccurate, particularly if they are negative. In a meta-analysis of studies comparing RADT and throat culture for GAS, RADT had a sensitivity of 86 percent (95% CI 83-88 percent) and a specificity of 95 percent (95% CI 94-96 percent) [<a href="#rid84">84</a>]. (See  <a class="medical medical_review" href="/d/html/5971.html" rel="external">"Group A streptococcal tonsillopharyngitis in children and adolescents: Clinical features and diagnosis", section on 'RADT for GAS'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A clinically significant rise in antistreptococcal antibody (antistreptolysin O [ASO] and/or anti-DNase B [ADB]) titers between the onset of symptoms and four to six weeks later [<a href="#rid78">78</a>]. It is important to obtain ADB as well as ASO titers since ADB titers are elevated in approximately 80 percent of PANDAS cases, whereas ASO titers are elevated in only 20 to 50 percent of cases [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent2">The diagnosis of PANDAS (but not pediatric acute-onset neuropsychiatric syndrome [PANS]) is unlikely if antistreptococcal antibodies are undetectable or low. Such negative test results can be helpful in removing PANDAS from a differential diagnosis. The autoantibodies thought to be responsible for the neuropsychiatric symptoms should rise in parallel with the antistreptococcal antibodies. It would be improbable to have sufficient autoantibodies to cause neuropsychiatric symptoms without concomitant elevation of other measurable antistreptococcal antibodies. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent2">Although it is likely that the antibody response in PANDAS is similar to that of other types of GAS infections, this has not been systematically studied. The antibody response of ASO peaks three to five weeks after GAS pharyngitis and the antibody response of ADB peaks six to eight weeks after GAS pharyngitis [<a href="#rid85">85,86</a>]. Antibody titers fall off rapidly in the next several months and, after six months, have a slower decline. A key concept is that a measurable antibody titer could be from a fairly recent infection or an infection months or even a year earlier, although very high levels suggest more recent infections and a titer that increases compared with a prior titer should be construed to indicate that a GAS infection occurred in the interim between the titers.</p><p></p><p class="bulletIndent2">The antibody response to GAS pharyngitis is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/3177.html" rel="external">"Acute rheumatic fever: Clinical manifestations and diagnosis", section on 'Evidence of preceding GAS infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preliminary interpretation</strong> – A diagnosis of probable PANDAS may be suspected in children with:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Abrupt onset of neuropsychiatric symptoms</p><p class="bulletIndent2"><span class="glyph">•</span>Evidence of recent GAS infection</p><p class="bulletIndent2"><span class="glyph">•</span>Remission of neuropsychiatric symptoms with antistreptococcal antibiotic therapy</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring for neuropsychiatric symptoms</strong> – Monitoring for occurrence of neuropsychiatric symptoms temporally associated with evidence of GAS infection is warranted for patients in whom a diagnosis of probable PANDAS is being considered. In a prospective study, approximately 50 percent of patients with a diagnosis of probable PANDAS had recurrence of neuropsychiatric symptoms associated with GAS infections [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent1">Some authorities suggest repeat cultures and/or serology when children with suspected recurrent episodes of PANDAS are well to exclude streptococcal carriers [<a href="#rid1">1,14,78,83</a>]. Demonstration of negative throat culture or declining antistreptococcal antibody titers during remission of neuropsychiatric symptoms decreases the likelihood of GAS carriage [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Trial of prophylactic antibiotics</strong> – The role of prophylactic antibiotics in the management of PANDAS is uncertain. If the pathogenesis of PANDAS is similar to that of acute rheumatic fever and Sydenham chorea, then prophylactic antibiotics may be expected to prevent recurrences of PANDAS as it does in these conditions [<a href="#rid87">87</a>]. However, the pathogenesis of PANDAS has not been established. (See  <a class="medical medical_review" href="/d/html/3175.html" rel="external">"Acute rheumatic fever: Treatment and prevention"</a> and  <a class="medical medical_review" href="/d/html/6228.html" rel="external">"Sydenham chorea"</a>.)</p><p></p><p class="bulletIndent1">Although some experts recommend against the use of prophylactic antibiotics for children with PANDAS [<a href="#rid14">14,15</a>], in the experience of the author of this topic, a brief trial of prophylactic antibiotics is an option to aid in the diagnosis and prevent symptom recurrences.</p><p></p><p class="bulletIndent1">The author uses one of the following regimens:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_pediatric" data-topicid="12631" href="/d/drug information/12631.html" rel="external">Amoxicillin</a> 250 mg orally twice per day (available in chewable tablets)</p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">Azithromycin</a> 5 mg/kg orally once per day (for children with penicillin allergy)</p><p></p><p class="bulletIndent1">Oral prophylaxis is preferred to monthly injections of intramuscular penicillin.</p><p></p><p class="bulletIndent1">The trial of prophylaxis should be long enough that a relapse of PANDAS symptoms would be expected to occur in the individual patient – generally a few months. It should be continued through one winter season, coinciding with the peak seasonal occurrence of GAS. Prophylaxis is discontinued if neuropsychiatric symptoms do not improve or the child has a recurrence of neuropsychiatric symptoms. Prolonged antibiotic therapy is challenging and associated with substantial adverse consequences (eg, diarrhea, pseudomembranous colitis, candida infections, and increased rates of antibiotic resistance [<a href="#rid88">88</a>]).</p><p></p><p class="bulletIndent1">The clinical course during prophylaxis may provide insight into the disease for the patient/caregiver and clinician:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Remission of neuropsychiatric symptoms supports the potential diagnosis of PANDAS</p><p class="bulletIndent2"><span class="glyph">•</span>Recurrence of neuropsychiatric symptoms during prophylaxis excludes the diagnosis </p><p></p><p class="bulletIndent1">Observational studies suggest an association between prophylactic antibiotics and decreased frequency of GAS infections, decreased frequency of neuropsychiatric exacerbations, and improvement in neuropsychiatric symptoms [<a href="#rid7">7,89</a>]. In the only placebo-controlled trial, an equal number of GAS infections occurred in the penicillin and placebo groups; failure to achieve adequate prophylaxis against GAS prohibited drawing conclusions regarding efficacy of PANDAS prevention [<a href="#rid90">90</a>]. A subsequent study compared rates of streptococcal infections and neuropsychiatric symptom exacerbation before and during 12 months of prophylaxis with penicillin or <a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">azithromycin</a> [<a href="#rid7">7</a>]. Prophylaxis was associated with fewer episodes of GAS infection and fewer neuropsychiatric exacerbations compared with baseline. However, the lack of a placebo group and other design problems (eg, small numbers, inadequate blinding, nonstandardized definition of exacerbation, failure to exclude GAS carriage) make these results inconclusive [<a href="#rid91">91</a>]. In a cohort of children with PANDAS, prophylactic intramuscular penicillin was associated with improvement in neurologic symptoms, primarily in the first three to five months of treatment; however, infection-related relapses occurred in 45 percent of patients over the long-term (five to seven years) [<a href="#rid89">89</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recommendations of others</strong> – The diagnostic process described above is that of the author of this topic.</p><p></p><p class="bulletIndent1">Investigators at the National Institutes of Mental Health (NIMH) have also outlined a diagnostic process [<a href="#rid1">1,14</a>]. They maintain that the risk of acute rheumatic fever mandates the detection and appropriate treatment of GAS infections, including mildly symptomatic infections and infections in which neuropsychiatric manifestations are the only symptoms. (See  <a class="medical medical_review" href="/d/html/3175.html" rel="external">"Acute rheumatic fever: Treatment and prevention"</a>.)</p><p></p><p class="bulletIndent1">The PANS Consensus Conference provides recommendations for the clinical evaluation and management of children with suspected PANS [<a href="#rid22">22,92-94</a>].</p><p></p><p class="bulletIndent1">The author's, NIMH, and PANS Consensus approaches to diagnostic evaluation of PANDAS/PANS are not endorsed by all experts. Although the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee and the American Academy of Pediatrics Committee on Infectious Diseases recommend evaluation for GAS in children with clinical symptoms and signs of acute GAS pharyngitis, they do not recommend routine laboratory testing for GAS to diagnose PANDAS in children with OCD/tic disorders or other neuropsychiatric symptoms [<a href="#rid15">15,39</a>].</p><p></p><p class="bulletIndent1">The evaluation of children with pharyngitis in the absence of neuropsychiatric manifestations is discussed separately. (See  <a class="medical medical_review" href="/d/html/6457.html" rel="external">"Evaluation of sore throat in children"</a> and  <a class="medical medical_review" href="/d/html/5971.html" rel="external">"Group A streptococcal tonsillopharyngitis in children and adolescents: Clinical features and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H13"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The major considerations in the differential diagnosis of PANDAS are obsessive-compulsive disorder (OCD)/tic disorder in a child with coincident intercurrent episodes of GAS infection or a child with GAS carriage and Sydenham chorea [<a href="#rid1">1,14,16,87</a>].</p><p class="headingAnchor" id="H14"><span class="h2">Tic disorder or OCD</span><span class="headingEndMark"> — </span>Both neuropsychiatric symptoms and GAS are common in prepubertal children. OCD occurs in 1 to 2 percent of school-age children and transient motor tics in as many as 25 percent [<a href="#rid95">95-97</a>]. GAS accounts for 15 to 30 percent of all cases of pharyngitis in children between the ages of 5 and 15 years. Prospective surveillance identified GAS carriage in 2.5 percent of well children and 4.4 percent of children with upper respiratory infection (including a sore throat) [<a href="#rid98">98</a>]. (See  <a class="medical medical_review" href="/d/html/86436.html" rel="external">"Obsessive-compulsive disorder in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis", section on 'Epidemiology'</a>.)</p><p>Strict adherence to the diagnostic process described above should help to distinguish between PANDAS and coincidental simultaneous occurrence of these problems [<a href="#rid14">14</a>]. Documenting negative throat culture and/or declining antistreptococcal antibody titers during remission helps to exclude GAS carriage. (See <a class="local">'Diagnostic process'</a> above.)</p><p class="headingAnchor" id="H15"><span class="h2">Sydenham chorea</span><span class="headingEndMark"> — </span>Sydenham chorea is a movement disorder characterized by chorea, emotional lability, and hypotonia. Neuropsychiatric manifestations that may be present in Sydenham chorea also may occur in PANDAS patients (eg, OCD, separation anxiety, hyperactivity, adventitious movements) [<a href="#rid10">10,87,99</a>]. (See  <a class="medical medical_review" href="/d/html/6228.html" rel="external">"Sydenham chorea"</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">NATURAL HISTORY</span><span class="headingEndMark"> — </span>The natural history of PANDAS was described in a prospective case-control study of 40 children with PANDAS and 40 children with obsessive-compulsive disorder (OCD)/tic disorders but no evidence of GAS infection [<a href="#rid23">23</a>]. Throat cultures were obtained once per month, and streptococcal antibody titers were measured at least once every three months, for two years; testing for GAS also was performed during exacerbations. Case subjects were treated with standard therapies for their neuropsychiatric symptoms and received prompt antibiotic therapy for GAS infections. Prophylactic antibiotics and immune modulating therapy were not administered. Laboratory personnel were blinded to the status of the patient (case versus control and exacerbation versus routine monitoring), and clinical raters were blinded to the laboratory results.</p><p>The following observations were made [<a href="#rid23">23</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Forty neuropsychiatric exacerbations (clinically significant worsening for ≥5 days unrelated to a change in medication) occurred in 21 case patients (0.56 exacerbations per person year), and 25 neuropsychiatric exacerbations occurred in 14 control subjects (0.28 exacerbations per person year). These rates were lower than expected.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Only five neuropsychiatric exacerbations occurred within four weeks of GAS infection; all of these occurred in PANDAS patients. This was greater than the number expected by chance (1.6).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Definite or probable GAS infection was more frequent among cases than controls (0.43 versus 0.13 infections per person-year; relative risk 2.76, 95% CI 1.4-5.3).</p><p></p><p>These observations and those from other studies suggest that a subgroup of patients with tics/OCD may be vulnerable to GAS as a precipitant of neuropsychiatric symptoms, but the majority of exacerbations have other triggers [<a href="#rid23">23,26,38</a>].</p><p class="headingAnchor" id="H17"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>The management of children with PANDAS is multidisciplinary and centers on providing standard therapies for GAS infection, obsessive-compulsive disorder (OCD)/tic disorder, and other neuropsychiatric disorders [<a href="#rid14">14,16,92</a>].</p><p class="headingAnchor" id="H18"><span class="h2">Antibiotic therapy</span><span class="headingEndMark"> — </span>Antibiotic therapy is indicated for the treatment of acute streptococcal infection as diagnosed by a positive throat culture or rapid antigen detection test (RADT) or positive skin culture from infected skin [<a href="#rid14">14</a>].</p><p class="headingAnchor" id="H19"><span class="h3">GAS infection</span><span class="headingEndMark"> — </span>Children with signs and symptoms of acute GAS infection and positive culture or RADT for GAS require antistreptococcal therapy (whether they have neuropsychiatric symptoms). Antimicrobial therapy is administered to reduce the severity and duration of signs and symptoms, including suppurative complications, reduce the incidence of nonsuppurative complications, and reduce the risk of transmission. Treatment of GAS pharyngitis is discussed separately. (See  <a class="medical medical_review" href="/d/html/8049.html" rel="external">"Treatment and prevention of streptococcal pharyngitis in adults and children"</a>.)</p><p class="headingAnchor" id="H20"><span class="h3">PANDAS subgroup</span><span class="headingEndMark"> — </span>For children with suspected PANDAS (ie, abrupt onset of neuropsychiatric symptoms and evidence of recent GAS infection), the author of this topic suggests treatment with <a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">azithromycin</a> or a cephalosporin rather than other antistreptococcal antibiotics or no antibiotics. Azithromycin is preferred for patients with suspected PANDAS previously treated with a penicillin or cephalosporin antibiotic without clear clinical benefit. Antistreptococcal therapy has been associated with prompt resolution of symptoms and prompt resolution is consistent with the diagnosis of probable PANDAS [<a href="#rid24">24</a>].</p><p><a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">Azithromycin</a> or cephalosporin therapy is provided even if the episode of GAS was already treated with a penicillin antibiotic (given the failure rates for penicillin and <a class="drug drug_pediatric" data-topicid="12631" href="/d/drug information/12631.html" rel="external">amoxicillin</a> therapy). (See  <a class="medical medical_review" href="/d/html/8049.html" rel="external">"Treatment and prevention of streptococcal pharyngitis in adults and children", section on 'Alternatives to penicillin'</a>.)</p><p>Suggested doses are as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">Azithromycin</a> 12 mg/kg orally in one dose for 5 days (maximum dose 500 mg/day)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13123" href="/d/drug information/13123.html" rel="external">Cefadroxil</a> 30 mg/kg per day orally in one dose for 10 days</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13138" href="/d/drug information/13138.html" rel="external">Cephalexin</a> 30 mg/kg per day orally in two divided doses for 10 days</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13137" href="/d/drug information/13137.html" rel="external">Cefuroxime</a> 30 mg/kg per day orally in two divided doses for 10 days</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13132" href="/d/drug information/13132.html" rel="external">Cefpodoxime</a> 10 mg/kg per day orally in two divided doses for 5 days</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13125" href="/d/drug information/13125.html" rel="external">Cefdinir</a> 14 mg/kg per day orally in two divided doses for 5 days</p><p></p><p>Although treatment with <a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">azithromycin</a> or <a class="drug drug_pediatric" data-topicid="13167" href="/d/drug information/13167.html" rel="external">clindamycin</a> is advocated by some experts because of the possibility that GAS is intracellular [<a href="#rid100">100-104</a>], the author of this topic prefers azithromycin because it has fewer adverse effects than clindamycin (eg, gastrointestinal symptoms, potential to cause <em>Clostridioides difficile</em>) and the suspension is more palatable. The author of this topic avoids <a class="drug drug_pediatric" data-topicid="12639" href="/d/drug information/12639.html" rel="external">amoxicillin-clavulanate</a> for the treatment of PANDAS. It does not provide improved intracellular penetration and is only active when bacteria are dividing.</p><p>There are no randomized controlled trials of antibiotic treatment of children suspected of having PANDAS syndrome. In a prospective study that identified 12 children with abrupt onset of neuropsychiatric symptoms and evidence of recent GAS infection, antistreptococcal (cephalosporin) therapy was associated with prompt symptom resolution in all cases [<a href="#rid24">24</a>]. Antistreptococcal therapy also was associated with prompt resolution of symptoms in the six patients who developed recurrent symptoms associated with GAS infection. The mean time to resolution of symptoms was shorter among children treated with cephalosporin than with penicillin (5 to 6 versus 14 days, respectively).</p><p class="headingAnchor" id="H21"><span class="h2">Neuropsychiatric therapy</span><span class="headingEndMark"> — </span>Children with OCD, tic disorders, and/or other neuropsychiatric disorders should receive individualized standard neuropsychiatric treatment for these disorders (whether the children have evidence of recent GAS infection) [<a href="#rid14">14,16,92</a>]. Treatment of neuropsychiatric symptoms should not be delayed pending confirmation of PANDAS (eg, documenting rise in antistreptococcal antibodies or while monitoring for a second episode).</p><p>The neuropsychiatric manifestations of children in the PANDAS subgroup respond to treatment with standard pharmacologic and behavior therapies [<a href="#rid14">14</a>]. OCD symptoms generally respond to a combination of pharmacotherapy (typically a selective serotonin reuptake inhibitor) and cognitive-behavioral therapy. Motor and vocal tics can be treated with a variety of medications. (See  <a class="medical medical_review" href="/d/html/90748.html" rel="external">"Obsessive-compulsive disorder in children and adolescents: Treatment overview"</a> and  <a class="medical medical_review" href="/d/html/126069.html" rel="external">"Tourette syndrome: Management", section on 'Approach to management'</a>.)</p><p class="headingAnchor" id="H3621472933"><span class="h2">Other therapies</span></p><p class="headingAnchor" id="H22"><span class="h3">Immune modulating therapy</span><span class="headingEndMark"> — </span>Immune modulating therapies include plasma exchange, intravenous <a class="drug drug_pediatric" data-topicid="83878" href="/d/drug information/83878.html" rel="external">immune globulin</a> (IVIG), glucocorticoids, and nonsteroidal anti-inflammatory drugs (NSAIDs) [<a href="#rid105">105</a>]. If PANDAS is an autoimmune disorder (and this remains controversial), immunomodulatory treatments might be beneficial, but they are as yet unproven and they carry risks [<a href="#rid106">106,107</a>]. Although the pediatric acute-onset neuropsychiatric syndrome (PANS) Collaborative Consensus group has proposed indications for use of immunomodulatory therapies in children with PANS/PANDAS [<a href="#rid93">93</a>], the author of this topic and other experts caution against their routine use [<a href="#rid34">34</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Plasma exchange or </strong><a class="drug drug_pediatric" data-topicid="83878" href="/d/drug information/83878.html" rel="external">IVIG</a> – The potential benefits of treatment with plasma exchange or IVIG compared with placebo were evaluated in a randomized controlled trial in 29 children who met PANDAS criteria and were severely affected [<a href="#rid73">73</a>]. Symptom severity was rated at baseline and at 1 and 12 months after treatment. Substantial improvement in symptoms from baseline was noted in the treatment groups at one month; improvements were maintained at one year, although psychotropic medications were decreased or discontinued in only 7 of 13 patients who required them at baseline. Adverse effects occurred in approximately two-thirds of patients in the treatment groups and included nausea, vomiting, headache, and dizziness.</p><p></p><p class="bulletIndent1">Limitations of the trial included the lack of a control for plasma exchange, open treatment of controls after the one-month follow-up (making it impossible to exclude the possibility of spontaneous improvement in the control group at the 12-month follow-up), lack of correlation between therapeutic response and rate of antibody removal, and poorly understood mechanism of therapeutic benefit [<a href="#rid33">33,73</a>].</p><p></p><p class="bulletIndent1">A subsequent randomized trial of <a class="drug drug_pediatric" data-topicid="83878" href="/d/drug information/83878.html" rel="external">IVIG</a> in 35 children who met criteria for PANDAS and moderate to severe OCD failed to demonstrate a benefit of IVIG over placebo [<a href="#rid108">108</a>].</p><p></p><p class="bulletIndent1">A subsequent open trial of plasma exchange in children with OCD who did not meet PANDAS criteria failed to demonstrate a benefit [<a href="#rid74">74</a>]. This finding suggests that the effects of plasma exchange in children with OCD may be limited to those with preceding GAS infection, lending support to the autoimmune hypothesis. (See <a class="local">'Autoimmunity'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Oral glucocorticoids</strong> – The effects of oral glucocorticoid treatment of PANS/PANDAS flares were evaluated in a retrospective study of 98 patients who met research criteria for PANS/PANDAS and had a total of 403 flares, 85 of which were treated with oral glucocorticoid [<a href="#rid106">106</a>]. Administration of oral glucocorticoids was associated with shorter duration of flares (6.4±5 weeks versus 11.4±8 weeks), particularly when administered early. Additional evaluation in a randomized controlled trial is necessary.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>NSAIDs </strong>– The effects of NSAID treatment of PANS/PANDAS flares were evaluated in a retrospective study of 95 patients who met research criteria for PANS/PANDAS and had a total of 390 flares for which duration could be assessed [<a href="#rid107">107</a>]. Among the 390 flares, 270 were not treated with NSAIDs, 43 were treated early with NSAIDs (within 30 days of flare onset), and 76 were treated prophylactically (use of NSAIDs before the flare and continued for the duration of the flare). The mean duration of untreated flare was 12.2 weeks; it was 2.6 weeks shorter with early NSAID treatment and 4 weeks shorter with prophylactic treatment. Additional evaluation in a randomized controlled trial is necessary.</p><p></p><p class="headingAnchor" id="H3428826213"><span class="h3">Tonsillectomy</span><span class="headingEndMark"> — </span>The author of this topic suggests against tonsillectomy for children with PANDAS unless they have other indications for tonsillectomy. (See  <a class="medical medical_review" href="/d/html/6296.html" rel="external">"Tonsillectomy and/or adenoidectomy in children: Indications and contraindications", section on 'Indications'</a>.)</p><p>A systematic review of five studies evaluating tonsillectomy for children with PANDAS found no clear evidence of benefit [<a href="#rid109">109</a>]. The risks of tonsillectomy are discussed separately. (See  <a class="medical medical_review" href="/d/html/88054.html" rel="external">"Tonsillectomy (with or without adenoidectomy) in children: Postoperative care and complications", section on 'Complications'</a>.)</p><p class="headingAnchor" id="H23"><span class="h2">Referral indications</span><span class="headingEndMark"> — </span>Referral to a specialist (neurologist, psychiatrist, mental health provider) for treatment of OCD, tic disorder, or other neuropsychiatric symptoms may be indicated for children who meet criteria for PANDAS. (See <a class="local">'Neuropsychiatric therapy'</a> above.)</p><p>Referral to a rheumatologist/immunologist for consideration of other diagnoses also may be warranted for patients with severe symptoms that are unresponsive to standard therapies.</p><p class="headingAnchor" id="H24"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The long-term outcome of children who meet criteria for PANDAS is not known. Cases of carditis (as occurs in patients with Sydenham chorea) have not been reported [<a href="#rid16">16</a>]. Unrecognized PANDAS and untreated PANDAS may result in an increased risk of progression to lifelong obsessive-compulsive disorder and tic disorders that show the more typical waxing and waning pattern and are not associated with GAS infections [<a href="#rid23">23</a>].</p><p class="headingAnchor" id="H25"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>If the proposed model for PANDAS pathogenesis described above is correct, it might be possible to prevent PANDAS by preventing GAS infection. Recognition of the sentinel PANDAS episode and its prompt treatment may impact the likelihood of a recurrence and prevent kindling (eg, repeated stimulation of autoantibodies that target brain tissue, which eventually results in permanent destruction of the brain cells and permanent disability in the form of obsessive-compulsive or tic disorder). (See <a class="local">'PANDAS subgroup'</a> above.)</p><p>Measures to prevent GAS infection include early recognition and prompt initiation of antistreptococcal therapy and taking steps to decrease transmission. School-age children with sore throat or unexplained fever should be evaluated for GAS infection and treated with antibiotics if throat culture or rapid antigen detection test is positive. (See  <a class="medical medical_review" href="/d/html/8049.html" rel="external">"Treatment and prevention of streptococcal pharyngitis in adults and children"</a>.)</p><p class="headingAnchor" id="H28"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Background</strong> – Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci (PANDAS) is a term used to describe a subset of children whose symptoms of obsessive-compulsive disorder (OCD), tic disorders, or other neuropsychiatric symptoms are exacerbated by group A streptococcal (GAS) infection. The association between PANDAS and GAS is controversial. PANDAS is a subgroup of pediatric acute-onset neuropsychiatric syndrome (PANS), a diagnostic entity introduced to broaden the scope and allow for inciting events other than GAS. The pathogenesis of PANDAS and PANS is uncertain and there is controversy regarding their evaluation and management. (See <a class="local">'Background'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Working criteria</strong> – PANDAS is characterized by five working criteria (see <a class="local">'Clinical features'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>OCD and/or tic disorder</p><p class="bulletIndent2"><span class="glyph">•</span>Pediatric onset (between three years and onset of puberty)</p><p class="bulletIndent2"><span class="glyph">•</span>Abrupt onset and episodic course of symptoms</p><p class="bulletIndent2"><span class="glyph">•</span>Temporal relation between GAS infection and onset and/or exacerbation</p><p class="bulletIndent2"><span class="glyph">•</span>Neurologic abnormalities or tics during exacerbations</p><p></p><p class="bulletIndent1">The abrupt onset is most striking feature.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The author of this topic evaluates children who present with abrupt onset of OCD/tic disorder, separation anxiety, or urinary frequency (which can be a form of anxiety) for PANDAS by testing for GAS infection. (See <a class="local">'Diagnostic process'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A diagnosis of probable PANDAS may be suspected in children with: </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Abrupt onset of neuropsychiatric symptoms</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Evidence of recent GAS infection (positive throat culture or rapid antigen detection test [RADT] for GAS, positive skin culture from infected skin or rising antistreptococcal antibody titers)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Remission of neuropsychiatric symptoms with antistreptococcal therapy</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Children in whom a diagnosis of probable PANDAS is suspected should be monitored for occurrence of neuropsychiatric symptoms temporally associated with evidence of GAS infection.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A brief trial of prophylactic antibiotics can aid in the diagnosis:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Remission of symptoms during prophylaxis supports the diagnosis of PANDAS</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Recurrence of neuropsychiatric symptoms during prophylaxis excludes the diagnosis of PANDAS</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The major considerations in the differential diagnosis of PANDAS are OCD/tic disorder in a child with coincident intercurrent episodes of GAS infection or a child with GAS carriage and Sydenham chorea. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Children with positive culture or RADT for GAS require antistreptococcal therapy (whether they have associated neuropsychiatric symptoms). (See <a class="local">'GAS infection'</a> above and  <a class="medical medical_review" href="/d/html/8049.html" rel="external">"Treatment and prevention of streptococcal pharyngitis in adults and children"</a>.)</p><p></p><p class="bulletIndent1">For children with evidence of GAS infection temporally associated with abrupt onset of OCD, tic disorders, and other neuropsychiatric symptoms (ie, those in whom probable PANDAS is suspected), the author of this topic suggests antistreptococcal therapy with <a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">azithromycin</a> or cephalosporins rather than other antistreptococcal agents (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'PANDAS subgroup'</a> above.)</p><p></p><p class="bulletIndent1">Children with OCD, tic disorders, and other neuropsychiatric disorders require standard neuropsychiatric treatment if the symptoms do not remit after antibiotic therapy. (See <a class="local">'Neuropsychiatric therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Referral indications</strong> – Referral to a specialist (neurologist, psychiatrist, mental health provider) for treatment of OCD/tic disorder and other neuropsychiatric symptoms may be indicated for children who meet criteria for PANDAS.</p><p></p><p class="bulletIndent1">Referral to a rheumatologist/immunologist for consideration of other diagnoses also may be warranted for patients with severe symptoms that are unresponsive to standard therapies. (See <a class="local">'Referral indications'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998; 155:264.</a></li><li><a class="nounderline abstract_t">Murphy TK, Storch EA, Lewin AB, et al. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr 2012; 160:314.</a></li><li><a class="nounderline abstract_t">Swedo SE, Leckman JF, Rose NR. From research subgroup to clinical syndrome: Modifying the PANDAS criteria to describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome). Pediatr Ther 2012; 2.</a></li><li><a class="nounderline abstract_t">Prato A, Gulisano M, Scerbo M, et al. Diagnostic Approach to Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Narrative Review of Literature Data. Front Pediatr 2021; 9:746639.</a></li><li><a class="nounderline abstract_t">Dop D, Marcu IR, Padureanu R, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (Review). Exp Ther Med 2021; 21:94.</a></li><li><a class="nounderline abstract_t">Swedo SE. Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA 1994; 272:1788.</a></li><li><a class="nounderline abstract_t">Snider LA, Lougee L, Slattery M, et al. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 2005; 57:788.</a></li><li><a class="nounderline abstract_t">Allen AJ, Leonard HL, Swedo SE. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1995; 34:307.</a></li><li><a class="nounderline abstract_t">Swedo SE, Rapoport JL, Cheslow DL, et al. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry 1989; 146:246.</a></li><li><a class="nounderline abstract_t">Swedo SE, Leonard HL, Schapiro MB, et al. Sydenham's chorea: Physical and psychological symptoms of St Vitus dance. Pediatrics 1993; 91:706.</a></li><li><a class="nounderline abstract_t">Asbahr FR, Negrão AB, Gentil V, et al. Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: A prospective 6-month study. Am J Psychiatry 1998; 155:1122.</a></li><li><a class="nounderline abstract_t">Swedo SE, Leonard HL, Kiessling LS. Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics 1994; 93:323.</a></li><li><a class="nounderline abstract_t">Mell LK, Davis RL, Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 2005; 116:56.</a></li><li><a class="nounderline abstract_t">Swedo SE, Leonard HL, Rapoport JL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics 2004; 113:907.</a></li><li><a class="nounderline abstract_t">Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009; 119:1541.</a></li><li><a class="nounderline abstract_t">Kurlan R, Kaplan EL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics 2004; 113:883.</a></li><li><a class="nounderline abstract_t">Shulman ST. Pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS): update. Curr Opin Pediatr 2009; 21:127.</a></li><li><a class="nounderline abstract_t">Wald ER. A Pediatric Infectious Disease Perspective on Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infection and Pediatric Acute-onset Neuropsychiatric Syndrome. Pediatr Infect Dis J 2019; 38:706.</a></li><li><a class="nounderline abstract_t">Wilbur C, Bitnun A, Kronenberg S, et al. PANDAS/PANS in childhood: Controversies and evidence. Paediatr Child Health 2019; 24:85.</a></li><li><a class="nounderline abstract_t">Nielsen MØ, Köhler-Forsberg O, Hjorthøj C, et al. Streptococcal Infections and Exacerbations in PANDAS: A Systematic Review and Meta-analysis. Pediatr Infect Dis J 2019; 38:189.</a></li><li><a class="nounderline abstract_t">Hyman SE. PANDAS: Too Narrow a View of the Neuroimmune Landscape. Am J Psychiatry 2021; 178:5.</a></li><li><a class="nounderline abstract_t">Chang K, Frankovich J, Cooperstock M, et al. Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference. J Child Adolesc Psychopharmacol 2015; 25:3.</a></li><li><a class="nounderline abstract_t">Kurlan R, Johnson D, Kaplan EL, Tourette Syndrome Study Group. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics 2008; 121:1188.</a></li><li><a class="nounderline abstract_t">Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 2002; 156:356.</a></li><li><a class="nounderline abstract_t">Leslie DL, Kozma L, Martin A, et al. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. J Am Acad Child Adolesc Psychiatry 2008; 47:1166.</a></li><li><a class="nounderline abstract_t">Leckman JF, King RA, Gilbert DL, et al. Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry 2011; 50:108.</a></li><li><a class="nounderline abstract_t">Orlovska S, Vestergaard CH, Bech BH, et al. Association of Streptococcal Throat Infection With Mental Disorders: Testing Key Aspects of the PANDAS Hypothesis in a Nationwide Study. JAMA Psychiatry 2017; 74:740.</a></li><li><a class="nounderline abstract_t">Asbahr FR, Ramos RT, Negrão AB, Gentil V. Case series: increased vulnerability to obsessive-compulsive symptoms with repeated episodes of Sydenham chorea. J Am Acad Child Adolesc Psychiatry 1999; 38:1522.</a></li><li><a class="nounderline abstract_t">Wald ER, Dashefsky B, Feidt C, et al. Acute rheumatic fever in western Pennsylvania and the tristate area. Pediatrics 1987; 80:371.</a></li><li><a class="nounderline abstract_t">Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1994; 124:9.</a></li><li><a class="nounderline abstract_t">Madsen T, Kalbak K. Investigation on rheumatic fever subsequent to some epidemics of septic sore throat (especially milk epidemics). Acta Pathol Microbiol Scand 1940; 37:305.</a></li><li><a class="nounderline abstract_t">Hysmith ND, Kaplan EL, Cleary PP, et al. Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci. J Pediatric Infect Dis Soc 2017; 6:187.</a></li><li><a class="nounderline abstract_t">Singer HS. PANDAS and immunomodulatory therapy. Lancet 1999; 354:1137.</a></li><li><a class="nounderline abstract_t">Gilbert DL, Mink JW, Singer HS. A Pediatric Neurology Perspective on Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute-Onset Neuropsychiatric Syndrome. J Pediatr 2018; 199:243.</a></li><li><a class="nounderline abstract_t">Mora S, Martín-González E, Flores P, Moreno M. Neuropsychiatric consequences of childhood group A streptococcal infection: A systematic review of preclinical models. Brain Behav Immun 2020; 86:53.</a></li><li><a class="nounderline abstract_t">Kaplan EL. PANDAS? PAND? Or both? Or neither? Assessing a (possible?) temporal or pathogenetic relationship with the Group A "streptococcal diseases complex". Contemp Pediatr 2000; 18:81.</a></li><li><a class="nounderline abstract_t">Luo F, Leckman JF, Katsovich L, et al. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 2004; 113:e578.</a></li><li><a class="nounderline abstract_t">Perrin EM, Murphy ML, Casey JR, et al. Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Arch Pediatr Adolesc Med 2004; 158:848.</a></li><li class="breakAll">American Academy of Pediatrics. Group A streptococcal infections. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.694.</li><li><a class="nounderline abstract_t">Lamothe H, Baleyte JM, Smith P, et al. Individualized Immunological Data for Precise Classification of OCD Patients. Brain Sci 2018; 8.</a></li><li><a class="nounderline abstract_t">Gilbert DL, Kurlan R. PANDAS: horse or zebra? Neurology 2009; 73:1252.</a></li><li class="breakAll">PANDAS Information. Pediatrics and Developmental Neuroscience Branch National Institutes of Mental Health. intramural.nimh.nih.gov/pdn/web.htm (Accessed on September 07, 2011).</li><li><a class="nounderline abstract_t">Quigley EMM. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Curr Neurol Neurosci Rep 2017; 17:94.</a></li><li><a class="nounderline abstract_t">Clapp M, Aurora N, Herrera L, et al. Gut microbiota's effect on mental health: The gut-brain axis. Clin Pract 2017; 7:987.</a></li><li><a class="nounderline abstract_t">Quagliariello A, Del Chierico F, Russo A, et al. Gut Microbiota Profiling and Gut-Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections. Front Microbiol 2018; 9:675.</a></li><li><a class="nounderline abstract_t">Loffredo L, Spalice A, Salvatori F, et al. Oxidative stress and gut-derived lipopolysaccharides in children affected by paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. BMC Pediatr 2020; 20:127.</a></li><li><a class="nounderline abstract_t">Köhler-Forsberg O, Petersen L, Gasse C, et al. A Nationwide Study in Denmark of the Association Between Treated Infections and the Subsequent Risk of Treated Mental Disorders in Children and Adolescents. JAMA Psychiatry 2019; 76:271.</a></li><li><a class="nounderline abstract_t">Murphy TK, Snider LA, Mutch PJ, et al. Relationship of movements and behaviors to Group A Streptococcus infections in elementary school children. Biol Psychiatry 2007; 61:279.</a></li><li><a class="nounderline abstract_t">Tucker DM, Leckman JF, Scahill L, et al. A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified. J Am Acad Child Adolesc Psychiatry 1996; 35:1684.</a></li><li><a class="nounderline abstract_t">Xu J, Liu RJ, Fahey S, et al. Antibodies From Children With PANDAS Bind Specifically to Striatal Cholinergic Interneurons and Alter Their Activity. Am J Psychiatry 2021; 178:48.</a></li><li><a class="nounderline abstract_t">Church AJ, Dale RC, Lees AJ, et al. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 2003; 74:602.</a></li><li><a class="nounderline abstract_t">Pavone P, Bianchini R, Parano E, et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol 2004; 30:107.</a></li><li><a class="nounderline abstract_t">Dale RC, Heyman I, Giovannoni G, Church AW. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. Br J Psychiatry 2005; 187:314.</a></li><li><a class="nounderline abstract_t">Cox CJ, Zuccolo AJ, Edwards EV, et al. Antineuronal antibodies in a heterogeneous group of youth and young adults with tics and obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2015; 25:76.</a></li><li><a class="nounderline abstract_t">Chain JL, Alvarez K, Mascaro-Blanco A, et al. Autoantibody Biomarkers for Basal Ganglia Encephalitis in Sydenham Chorea and Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infections. Front Psychiatry 2020; 11:564.</a></li><li><a class="nounderline abstract_t">Shimasaki C, Frye RE, Trifiletti R, et al. Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms. J Neuroimmunol 2020; 339:577138.</a></li><li><a class="nounderline abstract_t">Singer HS, Gause C, Morris C, et al. Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics 2008; 121:1198.</a></li><li><a class="nounderline abstract_t">Kirvan CA, Swedo SE, Snider LA, Cunningham MW. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 2006; 179:173.</a></li><li><a class="nounderline abstract_t">Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003; 9:914.</a></li><li><a class="nounderline abstract_t">Cox CJ, Sharma M, Leckman JF, et al. Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease. J Immunol 2013; 191:5524.</a></li><li><a class="nounderline abstract_t">Kirvan CA, Cox CJ, Swedo SE, Cunningham MW. Tubulin is a neuronal target of autoantibodies in Sydenham's chorea. J Immunol 2007; 178:7412.</a></li><li><a class="nounderline abstract_t">Brimberg L, Benhar I, Mascaro-Blanco A, et al. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 2012; 37:2076.</a></li><li><a class="nounderline abstract_t">Lotan D, Benhar I, Alvarez K, et al. Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats. Brain Behav Immun 2014; 38:249.</a></li><li><a class="nounderline abstract_t">Singer HS, Mascaro-Blanco A, Alvarez K, et al. Neuronal antibody biomarkers for Sydenham's chorea identify a new group of children with chronic recurrent episodic acute exacerbations of tic and obsessive compulsive symptoms following a streptococcal infection. PLoS One 2015; 10:e0120499.</a></li><li><a class="nounderline abstract_t">Morris-Berry CM, Pollard M, Gao S, et al. Anti-streptococcal, tubulin, and dopamine receptor 2 antibodies in children with PANDAS and Tourette syndrome: single-point and longitudinal assessments. J Neuroimmunol 2013; 264:106.</a></li><li><a class="nounderline abstract_t">Dale RC. Tics and Tourette: a clinical, pathophysiological and etiological review. Curr Opin Pediatr 2017; 29:665.</a></li><li><a class="nounderline abstract_t">Singer HS, Hong JJ, Yoon DY, Williams PN. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005; 65:1701.</a></li><li><a class="nounderline abstract_t">Singer HS, Loiselle CR, Lee O, et al. Anti-basal ganglia antibodies in PANDAS. Mov Disord 2004; 19:406.</a></li><li><a class="nounderline abstract_t">Morris CM, Pardo-Villamizar C, Gause CD, Singer HS. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci 2009; 276:45.</a></li><li><a class="nounderline abstract_t">Brilot F, Merheb V, Ding A, et al. Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 2011; 76:1508.</a></li><li><a class="nounderline abstract_t">Dale RC, Church AJ, Candler PM, et al. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2006; 66:1612; author reply 1612.</a></li><li><a class="nounderline abstract_t">Rippel CA, Hong JJ, Yoon DY, et al. Methodologic factors affect the measurement of anti-basal ganglia antibodies. Ann Clin Lab Sci 2005; 35:121.</a></li><li><a class="nounderline abstract_t">Perlmutter SJ, Leitman SF, Garvey MA, et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999; 354:1153.</a></li><li><a class="nounderline abstract_t">Nicolson R, Swedo SE, Lenane M, et al. An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations. J Am Acad Child Adolesc Psychiatry 2000; 39:1313.</a></li><li><a class="nounderline abstract_t">Yaddanapudi K, Hornig M, Serge R, et al. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol Psychiatry 2010; 15:712.</a></li><li><a class="nounderline abstract_t">Loiselle CR, Lee O, Moran TH, Singer HS. Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Mov Disord 2004; 19:390.</a></li><li><a class="nounderline abstract_t">Frick LR, Rapanelli M, Jindachomthong K, et al. Differential binding of antibodies in PANDAS patients to cholinergic interneurons in the striatum. Brain Behav Immun 2018; 69:304.</a></li><li><a class="nounderline abstract_t">Johnson DR, Kurlan R, Leckman J, Kaplan EL. The human immune response to streptococcal extracellular antigens: Clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis 2010; 50:481.</a></li><li><a class="nounderline abstract_t">Singer HS, Giuliano JD, Zimmerman AM, Walkup JT. Infection: a stimulus for tic disorders. Pediatr Neurol 2000; 22:380.</a></li><li><a class="nounderline abstract_t">Pichichero ME. The PANDAS syndrome. Adv Exp Med Biol 2009; 634:205.</a></li><li><a class="nounderline abstract_t">Swedo SE, Rapoport JL, Leonard H, et al. Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry 1989; 46:335.</a></li><li><a class="nounderline abstract_t">Leonard HL, Swedo SE, Lenane MC, et al. A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Arch Gen Psychiatry 1993; 50:429.</a></li><li><a class="nounderline abstract_t">Perlmutter SJ, Garvey MA, Castellanos X, et al. A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry 1998; 155:1592.</a></li><li><a class="nounderline abstract_t">Cohen JF, Bertille N, Cohen R, Chalumeau M. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database Syst Rev 2016; 7:CD010502.</a></li><li><a class="nounderline abstract_t">Kaplan EL, Ferrieri P, Wannamaker LW. Comparison of the antibody response to streptococcal cellular and extracellular antigens in acute pharyngitis. J Pediatr 1974; 84:21.</a></li><li><a class="nounderline abstract_t">Ayoub EM, Wannamaker LW. Evaluation of the streptococcal desoxyribonuclease B and diphosphopyridine nucleotidase antibody tests in acute rheumatic fever and acute glomerulonephritis. Pediatrics 1962; 29:527.</a></li><li><a class="nounderline abstract_t">Bottas A, Richter MA. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Pediatr Infect Dis J 2002; 21:67.</a></li><li><a class="nounderline abstract_t">Scolnick B. Pediatric autoimmune neuropsychiatric disorders associated with streptococcus. Pediatrics 2009; 123:e171; author reply e171.</a></li><li><a class="nounderline abstract_t">Lepri G, Rigante D, Bellando Randone S, et al. Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome. J Child Adolesc Psychopharmacol 2019; 29:608.</a></li><li><a class="nounderline abstract_t">Garvey MA, Perlmutter SJ, Allen AJ, et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999; 45:1564.</a></li><li><a class="nounderline abstract_t">Budman C, Coffey B, Dure L, et al. Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders". Biol Psychiatry 2005; 58:917; author reply 918.</a></li><li><a class="nounderline abstract_t">Thienemann M, Murphy T, Leckman J, et al. Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part I-Psychiatric and Behavioral Interventions. J Child Adolesc Psychopharmacol 2017; 27:566.</a></li><li><a class="nounderline abstract_t">Frankovich J, Swedo S, Murphy T, et al. Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part II-Use of Immunomodulatory Therapies. J Child Adolesc Psychopharmacol 2017; 27:574.</a></li><li><a class="nounderline abstract_t">Cooperstock MS, Swedo SE, Pasternack MS, Murphy TK. Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part III-Treatment and Prevention of Infections. J Child Adolesc Psychopharmacol 2017; 27:594.</a></li><li><a class="nounderline abstract_t">Snider LA, Swedo SE. Pediatric obsessive-compulsive disorder. JAMA 2000; 284:3104.</a></li><li><a class="nounderline abstract_t">Zohar AH. The epidemiology of obsessive-compulsive disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am 1999; 8:445.</a></li><li><a class="nounderline abstract_t">Snider LA, Seligman LD, Ketchen BR, et al. Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics 2002; 110:331.</a></li><li><a class="nounderline abstract_t">Pichichero ME, Marsocci SM, Murphy ML, et al. Incidence of streptococcal carriers in private pediatric practice. Arch Pediatr Adolesc Med 1999; 153:624.</a></li><li><a class="nounderline abstract_t">Murphy TK, Goodman WK, Ayoub EM, Voeller KK. On defining Sydenham's chorea: where do we draw the line? Biol Psychiatry 2000; 47:851.</a></li><li class="breakAll">PANDAS Physician Network. Treatment of PANS/PANDAS with antibiotics. https://www.pandasppn.org/treatment-of-panspandas-with-antibiotics/ (Accessed on May 19, 2015).</li><li><a class="nounderline abstract_t">Osterlund A, Engstrand L. An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium--studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol 1997; 117:883.</a></li><li><a class="nounderline abstract_t">Osterlund A, Popa R, Nikkilä T, et al. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 1997; 107:640.</a></li><li><a class="nounderline abstract_t">Osterlund A, Engstrand L. Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro. Acta Otolaryngol 1995; 115:685.</a></li><li><a class="nounderline abstract_t">Thulin P, Johansson L, Low DE, et al. Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med 2006; 3:e53.</a></li><li><a class="nounderline abstract_t">Frankovich J, Swedo S, Murphy T, et al. Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part II-Use of Immunomodulatory Therapies. J Child Adolesc Psychopharmacol 2017; 27:574.</a></li><li><a class="nounderline abstract_t">Brown K, Farmer C, Farhadian B, et al. Pediatric Acute-Onset Neuropsychiatric Syndrome Response to Oral Corticosteroid Bursts: An Observational Study of Patients in an Academic Community-Based PANS Clinic. J Child Adolesc Psychopharmacol 2017; 27:629.</a></li><li><a class="nounderline abstract_t">Brown KD, Farmer C, Freeman GM Jr, et al. Effect of Early and Prophylactic Nonsteroidal Anti-Inflammatory Drugs on Flare Duration in Pediatric Acute-Onset Neuropsychiatric Syndrome: An Observational Study of Patients Followed by an Academic Community-Based Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic. J Child Adolesc Psychopharmacol 2017; 27:619.</a></li><li><a class="nounderline abstract_t">Williams KA, Swedo SE, Farmer CA, et al. Randomized, Controlled Trial of Intravenous Immunoglobulin for Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections. J Am Acad Child Adolesc Psychiatry 2016; 55:860.</a></li><li><a class="nounderline abstract_t">Farhood Z, Ong AA, Discolo CM. PANDAS: A systematic review of treatment options. Int J Pediatr Otorhinolaryngol 2016; 89:149.</a></li></ol></div><div id="topicVersionRevision">Topic 6031 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9464208" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21868033" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : From research subgroup to clinical syndrome: Modifying the PANDAS criteria to describe PANS (Pediatric Acute-onset Neuropsychiatric Syndrome)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34778136" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Diagnostic Approach to Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Narrative Review of Literature Data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33363605" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (Review).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7661914" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15820236" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7896671" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2912267" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8464654" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Sydenham's chorea: physical and psychological symptoms of St Vitus dance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9699708" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Obsessive-compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8121747" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15995031" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15060242" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19246689" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15060240" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19242249" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS): update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30747831" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A Pediatric Infectious Disease Perspective on Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infection and Pediatric Acute-onset Neuropsychiatric Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30996598" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : PANDAS/PANS in childhood: Controversies and evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30325890" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Streptococcal Infections and Exacerbations in PANDAS: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33384008" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : PANDAS: Too Narrow a View of the Neuroimmune Landscape.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25325534" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18519489" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11929370" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18724258" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21241948" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Streptococcal upper respiratory tract infections and exacerbations of tic and obsessive-compulsive symptoms: a prospective longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28538981" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Association of Streptococcal Throat Infection With Mental Disorders: Testing Key Aspects of the PANDAS Hypothesis in a Nationwide Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10596252" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Case series: increased vulnerability to obsessive-compulsive symptoms with repeated episodes of Sydenham chorea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3627888" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Acute rheumatic fever in western Pennsylvania and the tristate area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7802743" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Persistence of acute rheumatic fever in the intermountain area of the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Investigation on rheumatic fever subsequent to some epidemics of septic sore throat (especially milk epidemics)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28204534" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10513701" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : PANDAS and immunomodulatory therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29793872" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A Pediatric Neurology Perspective on Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute-Onset Neuropsychiatric Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30818033" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Neuropsychiatric consequences of childhood group A streptococcal infection: A systematic review of preclinical models.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : PANDAS? PAND? Or both? Or neither? Assessing a (possible?) temporal or pathogenetic relationship with the Group A "streptococcal diseases complex"</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15173540" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15351749" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15351749" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30096863" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Individualized Immunological Data for Precise Classification of OCD Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19794126" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : PANDAS: horse or zebra?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19794126" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : PANDAS: horse or zebra?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29039142" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29071061" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Gut microbiota's effect on mental health: The gut-brain axis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29686658" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Gut Microbiota Profiling and Gut-Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32188439" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Oxidative stress and gut-derived lipopolysaccharides in children affected by paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30516814" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A Nationwide Study in Denmark of the Association Between Treated Infections and the Subsequent Risk of Treated Mental Disorders in Children and Adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17126304" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Relationship of movements and behaviors to Group A Streptococcus infections in elementary school children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8973076" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32539528" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Antibodies From Children With PANDAS Bind Specifically to Striatal Cholinergic Interneurons and Alter Their Activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12700302" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14984902" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16199788" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Incidence of anti-brain antibodies in children with obsessive-compulsive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25658702" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Antineuronal antibodies in a heterogeneous group of youth and young adults with tics and obsessive-compulsive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32670106" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Autoantibody Biomarkers for Basal Ganglia Encephalitis in Sydenham Chorea and Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31884258" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Evaluation of the Cunningham Panel™in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18519490" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16875742" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Antibody-mediated neuronal cell signaling in behavior and movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12819778" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24184556" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Brain human monoclonal autoantibody from sydenham chorea targets dopaminergic neurons in transgenic mice and signals dopamine D2 receptor: implications in human disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17513792" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Tubulin is a neuronal target of autoantibodies in Sydenham's chorea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22534626" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24561489" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25793715" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Neuronal antibody biomarkers for Sydenham's chorea identify a new group of children with chronic recurrent episodic acute exacerbations of tic and obsessive compulsive symptoms following a streptococcal infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24080310" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Anti-streptococcal, tubulin, and dopamine receptor 2 antibodies in children with PANDAS and Tourette syndrome: single-point and longitudinal assessments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28915150" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Tics and Tourette: a clinical, pathophysiological and etiological review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16207842" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15077238" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Anti-basal ganglia antibodies in PANDAS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18823914" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21411742" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16717245" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15945138" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Methodologic factors affect the measurement of anti-basal ganglia antibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10513708" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11026187" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19668249" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15077236" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29233751" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Differential binding of antibodies in PANDAS patients to cholinergic interneurons in the striatum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20067422" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10913730" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Infection: a stimulus for tic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19280860" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : The PANDAS syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2930330" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8498877" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9812123" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27374000" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Rapid antigen detection test for group A streptococcus in children with pharyngitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12119952" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Comparison of the antibody response to streptococcal cellular and extracellular antigens in acute pharyngitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Evaluation of the streptococcal desoxyribonuclease B and diphosphopyridine nucleotidase antibody tests in acute rheumatic fever and acute glomerulonephritis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11791105" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19117840" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Pediatric autoimmune neuropsychiatric disorders associated with streptococcus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31140830" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10376116" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16242121" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28722481" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part I-Psychiatric and Behavioral Interventions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36358107" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part II-Use of Immunomodulatory Therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36358106" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part III-Treatment and Prevention of Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11135753" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Pediatric obsessive-compulsive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10442225" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : The epidemiology of obsessive-compulsive disorder in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12165586" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10357305" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Incidence of streptococcal carriers in private pediatric practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10807957" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : On defining Sydenham's chorea: where do we draw the line?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10807957" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : On defining Sydenham's chorea: where do we draw the line?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9442832" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium--studies of asymptomatic carriers and in vitro cultured biopsies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9149167" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8928643" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16401174" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Viable group A streptococci in macrophages during acute soft tissue infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36358107" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part II-Use of Immunomodulatory Therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28714753" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Pediatric Acute-Onset Neuropsychiatric Syndrome Response to Oral Corticosteroid Bursts: An Observational Study of Patients in an Academic Community-Based PANS Clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28696786" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Effect of Early and Prophylactic Nonsteroidal Anti-Inflammatory Drugs on Flare Duration in Pediatric Acute-Onset Neuropsychiatric Syndrome: An Observational Study of Patients Followed by an Academic Community-Based Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27663941" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Randomized, Controlled Trial of Intravenous Immunoglobulin for Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27619047" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : PANDAS: A systematic review of treatment options.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
